MindMed
1 known investors
Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.
Investors · 1
Acquisitions · 1
Early investors' stakes continue via these dealsHealthMode
HealthMode was a San Francisco AI-driven digital health startup that built a platform using machine learning to automate and improve precision of patient monitoring during clinical drug trials.
Frequently asked questions
- What does MindMed do?
- Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.
- Who are MindMed's investors?
- MindMed's investors include Noetic.